U.S. markets closed
  • S&P 500

    4,232.60
    +30.98 (+0.74%)
     
  • Dow 30

    34,777.76
    +229.23 (+0.66%)
     
  • Nasdaq

    13,752.24
    +119.39 (+0.88%)
     
  • Russell 2000

    2,271.63
    +30.21 (+1.35%)
     
  • Crude Oil

    64.82
    +0.11 (+0.17%)
     
  • Gold

    1,832.00
    +16.30 (+0.90%)
     
  • Silver

    27.57
    +0.09 (+0.32%)
     
  • EUR/USD

    1.2168
    +0.0100 (+0.83%)
     
  • 10-Yr Bond

    1.5770
    +0.0160 (+1.02%)
     
  • GBP/USD

    1.3990
    +0.0097 (+0.70%)
     
  • USD/JPY

    108.5820
    -0.5030 (-0.46%)
     
  • BTC-USD

    58,240.28
    +2,674.38 (+4.81%)
     
  • CMC Crypto 200

    1,480.07
    +44.28 (+3.08%)
     
  • FTSE 100

    7,129.71
    +53.54 (+0.76%)
     
  • Nikkei 225

    29,357.82
    +26.45 (+0.09%)
     

Dicerna Pharmaceuticals Inc (DRNA) President and CEO Douglas Fambrough Bought $180,600 of Shares

GuruFocus.com
·1 min read

- By insider

President and CEO of Dicerna Pharmaceuticals Inc (30-Year Financial, Insider Trades) Douglas Fambrough (insider trades) bought 10,000 shares of DRNA on 09/01/2020 at an average price of $18.06 a share. The total cost of this purchase was $180,600.


Dicerna Pharmaceuticals Inc is a biopharmaceutical company. It develops ribonucleic acid interference-based pharmaceuticals for treating diseases involving liver, including rare, chronic liver, cardiovascular and viral infections. Dicerna Pharmaceuticals Inc has a market cap of $1.33 billion; its shares were traded at around $17.84 with and P/S ratio of 14.47. Dicerna Pharmaceuticals Inc had annual average EBITDA growth of 12.40% over the past five years. GuruFocus has detected 3 severe warning signs with Dicerna Pharmaceuticals Inc. .

CEO Recent Trades:

  • President and CEO Douglas Fambrough bought 10,000 shares of DRNA stock on 09/01/2020 at the average price of $18.06. The price of the stock has decreased by 1.22% since.

Directors and Officers Recent Trades:

  • EVP & COO James B Weissman sold 4,360 shares of DRNA stock on 08/03/2020 at the average price of $22.47. The price of the stock has decreased by 20.61% since.

  • See Remarks Bob D Brown sold 8,185 shares of DRNA stock on 08/03/2020 at the average price of $22.48. The price of the stock has decreased by 20.64% since.

For the complete insider trading history of DRNA, click here

.This article first appeared on GuruFocus.